FOXA3 and hepatocellular carcinoma: In hepatocellular carcinoma, METTL14 induced HNF3γ mRNA m6A modification, resulting in reduced HNF3γ expression and poor response to treatment with the chemotherapy agent sorafenib (Zhou et al., 2020).